News

SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies…
Read More...

BioMarin Pharmaceutical Inc. and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a…
Read More...

Valneva SE a specialty vaccine company, today announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
Read More...

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the launch of the NAV3-33 Phase 3 clinical…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir tablets…
Read More...

Alpine Immune Sciences, Inc. and Horizon Therapeutics plc announced an exclusive license and collaboration agreement for the development and commercialization of up to four preclinical…
Read More...

Merck, known as MSD outside the United States and Canada, announced the European Commission (EC) has approved VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for active…
Read More...

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for spesolimab for the…
Read More...

Rakuten Medical, Inc announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application to begin clinical studies of…
Read More...

Immatics N.V. a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, and Bristol Myers Squibb announced that…
Read More...

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced a financing agreement with…
Read More...

Atea Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, today announced an updated strategy for AT-527 to address the rapidly evolving SARS-CoV-2 and emerging variants by…
Read More...

Pfizer Inc. announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial…
Read More...

Biogen Inc. and TheraPanacea announced that they have entered into a collaboration focused on multiple therapeutic areas in neuroscience, to further build on the companies’ existing…
Read More...

Merck, a leading science and technology company, announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the…
Read More...

Antengene Corporation Limited global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and…
Read More...

AgeX Therapeutics, Inc. a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a research collaboration with the University of…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Foghorn Therapeutics Inc. announced a strategic collaboration to create novel oncology medicines…
Read More...

Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company…
Read More...

Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca. The partnership is based on an expanded deal this year in May 2021 which…
Read More...